Skip to content
Bromelains
Bromelains is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
D03: Preparations for treatment of wounds and ulcers
D03B: Enzymes for treatment of wounds and ulcers
D03BA: Proteolytic enzymes for treatment of wounds and ulcers
D03BA03: Bromelains
M: Musculo-skeletal system drugs
M09: Other drugs for disorders of the musculo-skeletal system in atc
M09A: Other drugs for disorders of the musculo-skeletal system in atc
M09AB: Enzymes for disorders of the musculo-skeletal system
M09AB03: Bromelains
HCPCS
No data
Clinical
Clinical Trials
13 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.11112
Postoperative painD010149G89.18112
Male breast neoplasmsD01856711
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pseudomyxoma peritoneiD011553EFO_0007456112
Dental cariesD003731EFO_0003819K0211
Dental plaqueD00377311
NeoplasmsD009369C8011
Mucinous adenocarcinomaD00228811
Peritoneal neoplasmsD01053411
Respiratory distress syndromeD012128EFO_1000637J80111
Ventilator-associated pneumoniaD053717EFO_1001865J95.851111
PneumoniaD011014EFO_0003106J18111
PulpitisD011671EFO_1001139K04.011
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wound healingD014945GO_004206011
Cardiovascular diseasesD002318EFO_0000319I9811
EdemaD004487R60.911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBROMELAINS
INNbromelains
Description
Bromelain is an enzyme extract derived from the stems of pineapples, although it exists in all parts of the fresh pineapple. The extract has a history of folk medicine use. As an ingredient, it is used in cosmetics, as a topical medication, and as a meat tenderizer.
Classification
Unknown
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2109027
ChEBI ID
PubChem CID
DrugBank
UNII IDU182GP2CF3 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 200 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
35 adverse events reported
View more details